613 related articles for article (PubMed ID: 30735970)
21. Structural MRI correlates of cognitive function in multiple sclerosis.
Artemiadis A; Anagnostouli M; Zalonis I; Chairopoulos K; Triantafyllou N
Mult Scler Relat Disord; 2018 Apr; 21():1-8. PubMed ID: 29438835
[TBL] [Abstract][Full Text] [Related]
22. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
23. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
Šabanagić-Hajrić S; Suljić E; Kučukalić A
Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
[TBL] [Abstract][Full Text] [Related]
24. The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis.
van der Werf SP; Evers A; Jongen PJ; Bleijenberg G
Mult Scler; 2003 Feb; 9(1):89-94. PubMed ID: 12617274
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
[TBL] [Abstract][Full Text] [Related]
26. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.
Carotenuto A; Costabile T; Moccia M; Falco F; Scala MR; Russo CV; Saccà F; De Rosa A; Lanzillo R; Brescia Morra V
Mult Scler Relat Disord; 2019 Jan; 27():1-6. PubMed ID: 30273697
[TBL] [Abstract][Full Text] [Related]
27. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V;
Mult Scler Relat Disord; 2018 Oct; 25():112-121. PubMed ID: 30059895
[TBL] [Abstract][Full Text] [Related]
28. Patient-reported outcome measurements in a selective cohort of relapsing-remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics.
London F; El Sankari S; De Haan A; Benyahia Z; Landenne G; Duprez T; van Pesch V
Acta Neurol Belg; 2023 Jun; 123(3):1049-1059. PubMed ID: 36877357
[TBL] [Abstract][Full Text] [Related]
29. Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.
van der Hiele K; van Gorp DAM; Heerings MAP; Jongen PJ; van der Klink JJL; Beenakker EAC; van Eijk JJJ; Frequin STFM; van Geel BM; Hengstman GJD; Hoitsma E; Mostert JP; Verhagen WIM; de Gans K; Zemel D; Middelkoop HAM; Visser LH
Mult Scler Relat Disord; 2019 Jun; 31():5-11. PubMed ID: 30877926
[TBL] [Abstract][Full Text] [Related]
30. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
31. Depressive Symptoms and Suicidal Ideation in Progressive Multiple Sclerosis Compared With Relapsing-Remitting Multiple Sclerosis: Results From a Cross-sectional Survey.
Knowles LM; Esselman EC; Turner AP; Phillips KM; Herring TE; Alschuler KN; Ehde DM
Arch Phys Med Rehabil; 2021 Apr; 102(4):694-701. PubMed ID: 33080210
[TBL] [Abstract][Full Text] [Related]
32. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
[TBL] [Abstract][Full Text] [Related]
33. Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
Lamargue Hamel D; Deloire M; Ruet A; Charré-Morin J; Saubusse A; Ouallet JC; Brochet B
PLoS One; 2015; 10(11):e0142152. PubMed ID: 26555230
[TBL] [Abstract][Full Text] [Related]
34. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue.
Heesen C; Koehler G; Gross R; Tessmer W; Schulz KH; Gold SM
Mult Scler; 2005 Feb; 11(1):51-7. PubMed ID: 15732267
[TBL] [Abstract][Full Text] [Related]
35. Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis.
Lazzarotto A; Margoni M; Franciotta S; Zywicki S; Riccardi A; Poggiali D; Anglani M; Gallo P
Cerebellum; 2020 Apr; 19(2):192-200. PubMed ID: 31898280
[TBL] [Abstract][Full Text] [Related]
36. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Sundgren M; Wahlin Å; Maurex L; Brismar T
J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
[TBL] [Abstract][Full Text] [Related]
37. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms.
Skerrett TN; Moss-Morris R
J Psychosom Res; 2006 Nov; 61(5):587-93. PubMed ID: 17084135
[TBL] [Abstract][Full Text] [Related]
38. Employment and Gainful Earnings Among Those With Multiple Sclerosis.
Krause JS; Dismuke-Greer CE; Jarnecke M; Li C; Reed KS; Rumrill P
Arch Phys Med Rehabil; 2019 May; 100(5):931-937.e1. PubMed ID: 30529324
[TBL] [Abstract][Full Text] [Related]
39. Depression and Fatigue in Patients With Multiple Sclerosis Have No Influence on the Parameters of Cognitive Evoked Potentials.
Lazarevic S; Azanjac Arsic A; Aleksic D; Toncev G; Miletic-Drakulic S
J Clin Neurophysiol; 2021 Jan; 38(1):36-42. PubMed ID: 31725033
[TBL] [Abstract][Full Text] [Related]
40. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T
Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
